Lv743
3940 积分 2022-09-02 加入
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study
2天前
已完结
R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma
6天前
已完结
Reduced intracellular antioxidant capacity in platelets contributes to primary immune thrombocytopenia via ROS-NLRP3-caspase-1 pathway
7天前
已完结
Dual Functions of Bruton’s Tyrosine Kinase and Tec Kinase during Fcγ Receptor-Induced Signaling and Phagocytosis
8天前
已完结
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?
20天前
已完结
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink
21天前
已完结
Pathogenesis of immune thrombocytopenia
21天前
已完结
Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP
22天前
已完结
Immune Thrombocytopenia
22天前
已完结
Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives
22天前
已完结
皖公网安备34019202002308
